Neuroticism, side effects, and health perceptions among HIV-infected individuals on antiretroviral medications

Journal of Clinical Psychology in Medical Settings

Volumn 14, Issue 1, 2007, Pages 69-77

  Johnson, Mallory O ^a   Neilands, Torsten B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adherence; AIDS; Compliance; HIV; Neuroticism; Structural equation modeling; Symptom reporting

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ADULT; ANXIETY DISORDER; ARTICLE; ATTITUDE TO HEALTH; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPERIENCE; FEMALE; GASTROINTESTINAL DISEASE; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; LIPODYSTROPHY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MEDICAL ASSESSMENT; NAUSEA AND VOMITING; NEUROSIS; PATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY OF LIFE; RASH; SYMPTOM; TREATMENT OUTCOME; VIRUS LOAD;

EID: 34147181205     PISSN: 10689583     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10880-007-9056-9     Document Type: Article

References (68)

1. Ammassari, A., Murri, R., Pezzotti, P., Trotta, M., Ravisio, L., & DeLonis, P. (2001). Self reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection. Journal of Acquired Immune Deficiency Syndromes, 28, 445-449.
2. Arana, G. W. (2000). An overview of side effects caused by typical antipsychotics. Journal of Clinical Psychiatry, 61, 5-11.
3. Avia, M. D., Sanz, J., Sanchezbernardos, M. L., Martinezarias, M. R., Silva, F., & Grana, J. L. (1995). The 5-factor model. 2. Relations of the Neo-Pi with other personality variables. Personality and Individual Differences, 19, 81-97.
4. Bangsberg, D. R., Bronstone, A., & Hofmann, R. (2002). A computer-based assessment detects regimen misunderstandings and nonadherence for patients on HIV antiretroviral therapy. AIDS Care, 14, 3-15.
5. Barefoot, J. C., Beckham, J. C., Peterson, B. L., Haney, T. L., & Williams, R. B., Jr. (1992). Measures of neuroticism and disease status in coronary angiography patients. Journal of Consulting and Clinical Psychology, 60, 127-132.
6. Baron, R. M., & Kenny, D. A. (1986). The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. Journal of Personality and Social Psychology, 51, 1173-1182.
7. Barsky, A. J., Saintfort, R., Rogers, M. P., & Borus, J. F. (2002). Nonspecific medication side effects and the nocebo phenomenon. Journal of American Medical Association, 287, 622-627.
8. Bates, C. M. (1996). HIV medicine: Drug side effects and interactions. Postgraduate Medical Journal, 72, 30-36.
9. Beisecker, A. E., Cook, M. R., Ashworth, J., Hayes, J., Brecheisen, M., Helmig, L., et al. (1997). Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients. Psycho-Oncology, 6, 85-93.
10. Bentler, P. M., & Bonnett, D. G. (1980). Significance tests and goodness of fit in the analysis of covariance structures. Psychological Bulletin, 88, 588-606.
11. Bollen, K. A. (1989). Structural equations with latent variables. New York, NY, USA.
12. Browne, M. W., & Cudek, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models. Newbury Park, CA: Sage Publications.
13. Cameron, L., Leventhal, E. A., & Leventhal, H. (1993). Symptom representations and affect as determinants of care seeking in a community-dwelling, adult sample population. Health Psychology, 12, 171-179.
14. Carruth, A. K., & Boss, B. J. (1990). More than they bargained for: Adverse drug effects. Journal of Gerontological Nursing, 16, 27-31.
15. Chene, G., May, M., Costagliola, D., Monforte, A. D. A., Junghans, C., Wolf, F. D., et al. (2002). Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration. Paper presented at the XIV International AIDS Conference, Barcelona.
16. Costa, P. T., Fleg, J. L., McCrae, R. R., & Lakatta, E. G. (1982). Neuroticism, coronary artery disease, and chest pain complaints: Cross-sectional and longitudinal studies. Experimental Aging Research, 8, 37-44.
17. Costa, P. T., Jr. (1987). Influence of the normal personality dimension of neuroticism on chest pain symptoms and coronary artery disease. American Journal of Cardiology, 60, 20J-26J.
18. Costa, P. T., Jr., & McCrae, R. R. (1992). The NEO personality inventory-R: Professional manual. Odessa, FL: Psychological Assessment Resources.
19. Costa, P. T., Jr., & McCrae, R. R. (1985). Hypochondriasis, neuroticism, and aging. When are somatic complaints unfounded? American Psychology, 40, 19-28.
20. Costa, P. T., & McCrae, R. R. (1987). Neuroticism, somatic complaints, and disease: Is the bark worse than the bite? Journal of Personality. Special Issue: Personality and physical health, 55, 299-316.
21. Costa, P. T., & McCrae, R. R. (1988). Personality in adulthood: A six-year longitudinal study of self-reports and spouse ratings on the NEO Personality Inventory. Journal of Personality and Social Psychology, 54, 853-863.
22. Cunningham, W. E., Rana, H. M., Shapiro, M. F., & Hays, R. D. (1997). Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease. Journal of Clinical Epidemiology, 50, 829-835.
23. Davis, C., Ralevski, E., Kennedy, S. H., & Neitzert, C. (1995). The role of personality factors in the reporting of side effect complaints to moclobemide and placebo: A study of healthy male and female volunteers. Journal of Clinical Psychopharmacology, 15, 347-352.
24. Flora, D. B., & Curran, P. J. (2004). An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychological Methods, 9, 466-491.
25. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports [Review]. Patient Education & Counseling, 46, 93-108.
26. Gallant, M. P., & Connell, C. M. (2003). Neuroticism and depressive symptoms among spouse caregivers: Do health behaviors mediate this relationship? Psychology and Aging, 18, 587-592.
27. Gribble, J. N., Miller, H. G., Rogers, S. M., & Turner, C. F. (1999). Interview mode and measurement of sexual behaviors: Methodological issues. Journal of Sex Research, 36, 16-24.
28. Harris, P. R., & Lightsey, O. R., Jr. (2005). Constructive thinking as a mediator of the relationship between extraversion, neuroticism and subjective well-being. European Journal of Personality, 19, 409-426.
29. Hox, J. J. (2002). Multilevel analysis: Techniques and applications. Mahwah, New Jersey: Lawrence Erlbaum and Associates.
30. Hoyle, R. H., & Kenny, D. A. (1999). Sample size, reliability, and tests of statistical mediation. In R. H. Hoyle (Ed.), Statistical strategies for small sample research. Thousand Oaks, California: Sage Publications.
31. Hu, L.-T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling, 6, 1-55.
32. Huebner, D. M., Nemeroff, C. J., & Davis, M. C. (2005). Do hostility and neuroticism confound associations between perceived discrimination and depressive symptoms? Journal of Social & Clinical Psychology, 24, 723-740.
33. Johnson, M. O., Catz, S. L., Remien, R. H., Rotheram-Borus, M. J., Morin, S. F., Charlebois, E. D., et al. (2003). Theory guided, empirically supported avenues for intervention on HIV medication nonadherence: Findings from the healthy living project. AIDS Patient Care STDS, 17, 645-656.
34. Johnson, M. O., Charlebois, E., Morin, S. F., Catz, S. L., Goldstein, R. B., Remien, R. H., et al. (2005). Perceived adverse effects of antiretroviral therapy. Journal of Pain & Symptom Management, 29, 193-205.
35. Johnson, M. O., Elliott, T. R., Neilands, T. B., Morin, S. F., & Chesney, M. A. (2006). A social problem solving model of adherence to HIV medications. Health Psychology, 25, 355-363.
36. Johnson, M. O., & Folkman, S. (2004). Side effect and disease related symptom representations among HIV+adults on antiretroviral therapy. Psychology, Health & Medicine, 9, 139-148.
37. Johnson, M. O., Stallworth, T., & Neilands, T. B. (2003). The drugs or the disease? Causal attributions of symptoms held by HIV positive adults on HAART. AIDS and Behavior, 7, 109-117.
38. Johnson, S. C., & Gerber, J. G. (2000). Advances in HIV/AIDS therapy. Advances in Internal Medicine, 45, 1-40.
39. Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., et al. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77-90.
40. Kalichman, S. C., Rompa, D., & Cage, M. (2000). Reliability and validity of self-reported CD4 lymphocyte count and viral load test results in people living with HIV/AIDS. International Journal of STD & AIDS, 11, 579-585.
41. Keller, S. D., Majkut, T. C., Kosinski, M., & Ware, J. E., Jr. (1999). Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: Overview. Medical Care, 37, MS1-9.
42. Larsen, E. B., & Gerlach, J. (1996). Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenia out-patients treated with depot neuroleptics. Acta Psychiatrica Scandinavica, 93, 381-388.
43. Lightfoot, M., Rogers, T., Goldstein, R., Rotheram-Borus, M. J., May, S., Kirshenbaum, S., et al. (2005). Predictors of substance use frequency and reductions in seriousness of use among persons living with HIV. Drug and Alcohol Dependence, 77, 129-138.
44. Lorenz, K. A., Shapiro, M. F., Asch, S. M., Bozzette, S. A., & Hays, R. D. (2001). Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection. Annals of Internal Medicine, 134, 854-860.
45. MacKinnon, D. P., Lockwood, C. M., & Williams, J. (2004). Confidence limits for the indirect effect: Distribution of the product and resampling methods. Multivariate Behavioral Research, 39, 99-128.
46. McCrae, R. R., & Costa, P. T. (1991). The NEO personality inventory: Using the five-factor model in counseling. Journal of Counseling & Development, 69, 367-372.
47. McElroy, S. L., Keck, P. E., & Friedman, L. M. (1995). Minimizing and managing antidepressant side effects. Journal of Clinical Psychiatry, 56, 49-55.
48. McHorney, C. A., Ware, J. E., Lu, J. F. R., & Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Medical Care, 32, 40-66.
49. McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Medical Care, 31, 247-263.
50. Mohr, D. C., Likosky, W., Boudewyn, A. C., Marietta, P., Dwyer, P., Van Der Wende, J., et al. (1998). Side effect profile and adherence to in the treatment of multiple sclerosis with interferon beta-1a. Multiple Sclerosis, 4, 487-489.
51. Muthén, L. K., & Muthén, B. (2004). Mplus user's guide. Los Angeles, CA: Muthen and Muthen, Inc.
52. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annal of Internal Medicine, 133, 21-30.
53. Preacher, K. J., & Hayes, A. F. (2004). SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behavior Research Methods Instruments & Computers, 36, 717-731.
54. Ray-Chaudhuri, K., Abbott, R. J., & Millac, P. A. (1991). Subcutaneous apomorphine for parkinsonian patients with psychiatric side effects on oral treatment. Journal of Neurology, Neurosurgery & Psychiatry, 54, 372-373.
55. Richards, M. E., & Martinson, I. M. (1987). Patients' perceptions of the impact of chemotherapy side effects and their methods of coping with this impact. Loss, Grief & Care, 1, 53-70.
56. Ritsner, M., Ponizovsky, A., Endicott, J., Nechamkin, Y., Rauchverger, B., Silver, H., et al. (2002). The impact of side-effects of antipsychotic agents on life satisfaction of schizophrenia patients: A naturalistic study. European Neuropsychopharmacology, 12, 31-38.
57. Shapiro, D. E., Boggs, S. R., Rodrigue, J. R., & Urry, H. L. (1997). Stage II breast cancer: Differences between four coping patterns in side effects during adjuvant chemotherapy. Journal of Psychosomatic Research, 43, 143-157.
58. Shrout, P. E., & Bolger, N. (2002). Mediation in experimental and nonexperimental studies: New procedures and recommendations. Psychological Methods, 7, 422-445.
59. Turkkan, J. S. (1993). Antihypertensive pharmacotherapy side effects: Behavioral measurement and quality-of-life issues in clinical trials. Experimental & Clinical Psychopharmacology, 1.
60. Turner, C. F., Ku, L., Rogers, S. M., Lindberg, L. D., Pleck, J. H., & Sonenstein, F. L. (1998). Adolescent sexual behavior, drug use, and violence: Increased reporting with computer survey technology. Science, 280, 867-873.
61. Vandenberg, R. J., & Lance, C. E. (2000). A review and synthesis of the measurement invariance literature: Suggestions, practices, and recommendations for organizational research. Organizational Research Methods, 3, 4-69.
62. Volberding, P. A. (2003). HIV therapy in 2003: Consensus and controversy. Aids, 17 (Suppl 1), S4-11.
63. Ware, J. E., Gandek, B., & Group, I. P. (1994). The SF-36 health survey: Development and use in mental health research and the IQOLA Project. International Journal of Mental Health, 23, 49-73.
64. Ware, J. E., Jr. (1999). SF-36 health survey. In E. Mark & E. Maruish (Eds.), The use of psychological testing for treatment planning and outcomes assessment (2nd ed., pp. 1227-1246). NJ, US: Mahwah.
65. Ware, J. E., Jr., & Gandek, B. (1998). Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. Journal of Clinical Epidemiology, 51, 903-912.
66. Watson, D., & Pennebaker, J. W. (1989). Health complaints, stress, and distress: Exploring the central role of negative affectivity. Psychological Review, 96, 234-254.
67. Weinhardt, L. S., Kelly, J. A., Brondino, M. J., Rotheram-Borus, M. J., Kirshenbaum, S. B., Chesney, M. A., et al. (2004). HIV transmission risk behavior among men and women living with HIV in four U.S. cities. Journal of AIDS and Human Retrovirology, 36, 1057-1066.
68. Yu, C. Y. (2002). Evaluating cutoff criteria of model fit indices for latent variable models with binary and continuous outcomes. Los Angeles: University of California.